About
Plaio, founded in 2021 in Reykjavik, Iceland, offers software that helps pharmaceutical companies optimize supply chain management.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Funding history
- 2024-08New funding round$5M
Investors · Frumtak Ventures, IðunnSource · SVTR Weekly #066
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Plaio
Supply chain software for pharmaceutical companies, including demand forecasting, production planning and procurement
Undisclosed · $5M · 2024-08
$5M
United States
BusinessLatest roundTotal raisedDate- Modicus Prime
Helps pharmaceutical companies ensure AI systems meet GxP, audit and regulatory compliance requirements
$8M · 2026-05
$8M - PreemptiveAI
Uses smartphones and wearables to predict health outcomes for healthcare providers, pharmaceutical companies and insurance payers
Undisclosed · $6M · 2024-03
$6M - Cercle
AI analysis of medical data to help providers, insurers and pharma companies make data-driven decisions on women's health
Seed · $6M · 2024-09
$6M
China
BusinessLatest roundTotal raisedDate- Insilico Medicine
AI drug discovery company that uses generative models for target discovery and molecular design, and has advanced multiple drug candidates into clinical trials
Series D+ · $210M · 2025-03
$210M - 每因智能
Multimodal medical model applications: AI solutions for major disease risk prediction and disease risk management
Seed · 2025-04
— - iNAP Sleep
Brand operation of iNAP oral negative-pressure therapy for obstructive sleep apnea (OSA), adding AI prediction models and personalized treatment optimization on top of the negative-pressure hardware to raise treatment success rates and adherence
—
Europe
BusinessLatest roundTotal raisedDate- Arsenale Bioyards
Advanced bioreactors combined with AI-driven software to optimize fermentation in biomanufacturing
Undisclosed · $10M · 2025-03
$10M - Surgar
Augmented reality software to support surgeons during minimally invasive surgery
Undisclosed · $12M · 2024-09
$12M - Kneu Health
AI and smartphone monitoring to support clinical management of Parkinson's, dementia and other conditions
Seed · $6M · 2025-10
$6M
Other / unspecified
BusinessLatest roundTotal raisedDate- Reliant AI
Uses generative AI to help biopharma companies organize and analyze data for clinical trials or scientific publications
Seed · $11M · 2024-08
$11M - Sarborg
AI agents that help pharmaceutical companies optimize drug repurposing and clinical trial decisions
Seed · $10M · 2025-08
$10M - Craif
Urine microRNA plus AI early cancer detection service (miSignal) and software medical device development for pancreatic cancer diagnosis
Series D+ · $88M · 2026-08
$88M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.